UDAY_C_Santhakumar

Time to Revisit $SAGE -

看空
NASDAQ:SAGE   Sage Therapeutics, Inc.
This consolidation against a multi year resistance is key. This could potentially roll over (High Prob) or Breakout and go higher (Low Prob).

Depending on what you choose, please use your entry and exit techniques. Cut your losses if it goes against you.
評論:
That's what I am talking out. Testing intraday level, will it hit $35?

Uday C Santhakumar
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。